A deep dive into the Asian generic pharmaceutical landscape, comparing India's volume dominance with China's API control and the rise of emerging hubs.
Dec, 22 2025
Jan, 8 2026
Jan, 14 2026
Nov, 18 2025
Nov, 25 2025